Dubai: The Ministry of Health and Prevention (MoHAP) organised a dialogue session focused on the UAE's strategies to eliminate cervical cancer. The session gathered a group of experts and specialists in public health, vaccination, obstetrics and gynecology, oncology, and health economics, along with strategic partners.
According to Emirates News Agency, the session was attended by notable figures including Dr. Buthaina Bin Belaila, Head of the Non-Communicable Diseases and Mental Health Department; Dr. Laila Al-Jasmi, Head of the Communicable Diseases and Immunisation Department; Dr. Huda AlAbdouli, Consultant at MoHAP; Dr. Sara Al Dallal, President of the Emirates Health Economics Society at the Emirates Medical Association (EMA); and Prof. Bettina Borisch, CEO of the World Federation of Public Health Associations, along with other health authority experts and specialists.
The discussions highlighted national efforts and future plans aimed at eliminating HPV-related diseases. The session examined international best practices and insights from global experiences in vaccination, early detection, and public awareness, reinforcing the UAE's commitment to cervical cancer prevention and strengthening public health outcomes.
Dr. Buthaina Bin Belaila emphasized that the session is part of the Ministry's continuous efforts, in collaboration with its partners, to enhance preventive healthcare systems, advance evidence-based health policies, and support national initiatives to reduce HPV-related diseases. She pointed out that eliminating cervical cancer is a public health priority, supported by expanding vaccination programs, increasing access to early screening, and raising public awareness about prevention. She highlighted that the UAE is committed to developing policies and initiatives that safeguard community health and foster a prevention-centered healthcare model in line with international best practices.
The event included specialised scientific sessions exploring future directions for eliminating HPV-related diseases, as well as the UAE's progress in screening and vaccination efforts. Other sessions addressed cervical cancer treatment and the role of public awareness in prevention efforts and encouraging vaccination adherence.
Participants also discussed key factors influencing vaccination coverage for HPV immunisation programmes and solutions to improve access for target populations. The session reviewed Sweden's experience, international best practices, lessons learned, and innovative approaches in this field.
Discussions further explored methods to develop a national roadmap supporting vaccination, early detection, and health awareness programmes, while enhancing the integration of health policies, governance, and innovation in preventive healthcare.